Tracking a new treatment for debilitating nasal polyps
NCT ID NCT06393946
Summary
This study aims to gather real-world information on how adults in France with severe chronic sinusitis and nasal polyps are treated with the medication dupilumab (Dupixent). Researchers will follow 150 patients for two years to describe their health, prior treatments, and how they take the drug. The main goal is to observe the treatment's effectiveness on symptoms and its safety in everyday medical practice, not to test a new cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number: 250.0001
Nantes, 44093, France
Conditions
Explore the condition pages connected to this study.